Back to Archived Journals » Research and Reports in Medicinal Chemistry » Volume 2

Antifungal cyclic peptides from the marine sponge Microscleroderma herdmani

Authors Zhang, Jacob, Rao, Wang, Agarwal, Newman, Khan I, Clark, Li X

Received 25 February 2012

Accepted for publication 17 April 2012

Published 22 May 2012 Volume 2012:2 Pages 7—14

DOI https://doi.org/10.2147/RRMC.S30895

Review by Single-blind

Peer reviewer comments 3


Xiaohui Zhang,1 Melissa R Jacob,1 R Ranga Rao,1 Yan-Hong Wang,1 Ameeta K Agarwal,1 David J Newman,2 Ikhlas A Khan,1,3 Alice M Clark,1,3 Xing-Cong Li1,3

1National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, School of Pharmacy, The University of Mississippi, University, MS, 2Natural Products Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute – Frederick, Frederick, MD, 3Department of Pharmacognosy, School of Pharmacy, The University of Mississippi, University, MS, USA

Abstract: Screening natural product extracts from the National Cancer Institute Open Repository for antifungal discovery afforded hits for bioassay-guided fractionation. Using LC–MS analysis to generate chemical structure information on potentially active compounds, two new cyclic hexapeptides, microsclerodermins J (1) and K (2), were isolated from the deep-water sponge Microscleroderma herdmani, along with microsclerodermins A (3) and B (4), previously isolated from an unidentified Microscleroderma species. The structures of the new compounds were elucidated by spectroscopic analysis and chemical methods. In vitro antifungal testing showed that the four compounds possessed strong activities against the opportunistic fungal pathogens Candida albicans, Candida glabrata, Candida krusei, Cryptococcus neoformans, and Aspergillus fumigatus.

Keywords: antifungal, microsclerodermins, Microscleroderma herdmani, opportunistic fungal pathogens

Corrigendum for this paper has been published

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]